iTeos Therapeutics

📍 Cambridge, United States🗓 Founded 2011👥 136 employees💰 Last funded Feb 2013
Biotechnology Research🌐 iteostherapeutics.com
Website LinkedIn
iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of cancer immunology and immunosuppressive pathways to design novel product candidates with the potential to fully restore the immune response against cancer. The Company’s innovative pipeline includes two clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes. The first antibody product candidate, EOS-448, is a high affinity, potent, anti-TIGIT antibody with a functional Fc domain, designed to enhance the anti-tumor response through a multifaceted immune modulatory mechanism, currently progressing in multiple indications in collaboration with GSK. The Company is also advancing inupadenant, a next-generation adenosine A2A receptor antagonist tailored to overcome cancer immunosuppression into proof-of concept trials in several indications following encouraging single-agent activity in Phase 1. iTeos Therapeutics is headquartered in Cambridge, MA with a research center in Gosselies, Belgium.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2011
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
2
Frequently asked questions
Who invested in iTeos Therapeutics?
iTeos Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did iTeos Therapeutics last raise funding?
The most recent investment in iTeos Therapeutics recorded on gritt.io was in February 2013.
When was iTeos Therapeutics founded?
iTeos Therapeutics was founded in 2011.
What industry is iTeos Therapeutics in?
iTeos Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is iTeos Therapeutics based?
iTeos Therapeutics is headquartered in Cambridge, United States.